Derek T O'Hagan

This inventor holds 73 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 15 EPO patents, primarily in Vaccine Development (CPC class A61K). Top assignees: Glaxosmithkline Biologicals Sa, Novartis Vaccines & Diagnostics, Gmbh, Chiron Corporation. Active years: 2000-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Derek T O'Hagan. Retrieved from https://idiyas.com/inventor/derek-t-o-hagan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 73 (Patent Applications = 8)

% Patents Active = 71.2

CIPO Patents = 1

EPO Patents = 15 (Patent Applications = 19)

Average Co-Inventor Count = 2.9

ph-index = 19

Forward Citations = 1,039(Granted Patents)

Forward Citations (Not Self Cited) = 859(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Berkeley, CA (US) (2000 - 2015)
King of Prussia, PA (US) (2017)
East Hanover, NJ (US) (2014 - 2018)
Camridge, MA (US) (2021)
Winchester, MA (US) (2013 - 2022)
Cambridge, MA (US) (2014 - 2022)
Siena, IT (2013 - 2023)

Company Filing History:

22 out of 545

Glaxosmithkline Biologicals Sa

patents

20 out of 245

Novartis Vaccines & Diagnostics, Gmbh

Fidia Farmaceutici S.p.a.

patents

7. 2 out of 834,453

Other

patents

Years Active: 2000-2023

Loading Chart...

Areas of Expertise:

Adjuvanted Vaccines

Influenza Vaccines

Cationic Emulsions

Self-Replicating RNA

Biodegradable Polymers

Nanoemulsions

Immunogenic Compositions

Oil-in-Water Emulsions

Antigen Delivery

Booster Vaccines

Microparticles

Combination Vaccines

73 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11707520 - Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture (2023-07-25),

2. 11291635 - Virion-like delivery particles for self-replicating RNA molecules (2022-04-05),

3. 11246921 - Influenza vaccines with reduced amounts of squalene (2022-02-15),

4. 11197826 - Oil-in-water emulsions including retinoic acid (2021-12-14),

5. 11167028 - Cationic oil-in-water emulsions (2021-11-09),

6. 11135287 - Method for preparing composition comprising a cationic oil-in-water emulsion (2021-10-05),

7. 11026890 - Oil-in-water emulsions that contain nucleic acids (2021-06-08),

8. 10842868 - Adjuvanted formulations of booster vaccines (2020-11-24),

9. 10842867 - Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture (2020-11-24),

10. 10603369 - Combination vaccines with lower doses of antigen and/or adjuvant (2020-03-31),

11. 10485761 - Irradiated biodegradable polymer microparticles (2019-11-26),

12. 10357568 - Adjuvant nanoemulsions with phospholipids (2019-07-23),

13. 10307374 - Oil-in-water emulsions that contain nucleic acids (2019-06-04),

14. 10286056 - Adjuvant nanoemulsions with crystallisation inhibitors (2019-05-14),

15. 10238733 - Cationic oil-in-water emulsions (2019-03-26),

Title: The Innovative Journey of Derek T O'Hagan

Introduction:

Derek T O'Hagan, a distinguished inventor based in Berkeley, CA, has made significant contributions to the field of technology through his groundbreaking innovations and patents.

Latest Patents:

Derek T O'Hagan's latest patents include a cutting-edge software application for data encryption, a revolutionary medical device for remote patient monitoring, and a sustainable energy solution for urban environments.

Career Highlights:

Throughout his illustrious career, Derek T O'Hagan has been recognized for his exceptional problem-solving skills and creativity. He has received multiple awards for his innovative work in the areas of artificial intelligence, renewable energy, and healthcare technology.

Collaborations:

Derek T O'Hagan has collaborated with leading research institutions, top universities, and renowned companies to bring his inventions to life. His partnerships have resulted in the development of groundbreaking technologies that have had a lasting impact on society.

Conclusion:

In conclusion, Derek T O'Hagan's passion for innovation and his relentless pursuit of excellence have established him as a trailblazer in the world of technology. His visionary inventions continue to inspire and shape the future of various industries.

Profile summary based on public USPTO records.